Hoth Therapeutics, Inc. (HOTH) Dividend History

Hoth Therapeutics, Inc. is a biopharmaceutical company focused on developing targeted therapies for unmet medical needs. It emphasizes research in areas such as dermatology and neurological disorders, aiming to advance innovative treatments through strategic collaborations and proprietary platforms.

590 Madison Avenue, New York, NY, 10022
Phone: (646)756-2997
Website: https://www.hoththerapeutics.com

Dividend History

Hoth Therapeutics, Inc. currently does not pay dividends

Company News

  • Hoth Therapeutics (HOTH) rises on encouraging pre-clinical data demonstrating cognitive benefits of its novel therapeutic candidate, HT-ALZ, in the treatment of Alzheimer's disease.

    Zacks Investment Research
    Featured Companies: ACET ADMA FGEN
  • Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.70 million. Peraso shares tumbled 23.3% to $1.32 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Ontrak, Inc. (NASDAQ: OTRK) shares climbed 197.8% to $0.5660 ahead of the company's presentation at the 36th Annual Roth Conference. Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) gained 97.3% to $20.99 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21. SCWorx Corp. (NASDAQ: WORX) gained 74% to $3.22. Spire Global, Inc. (NYSE: SPIR) climbed 50.7% to $18.50 after announcing a collaboration with NVIDIA to advance AI-driven weather prediction. Enveric Biosciences, Inc (NASDAQ: ENVB) shares climbed 43.6% to $1.5801 after the company announced that it signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases. Zoomcar Holdings, Inc. (NASDAQ: ZCAR) rose 33.1% to $1.57 after the company announced that it partnered with EaseMyTrip to integrate its cars within the travel platform. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 32% to $1.51 after the company announced pre-clinical research showcasing the potential of HT-ALZ in Alzheimer's disease. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 27.2% to $16.09. The company announced a $90 million private placement financing and provided pipeline updates. National CineMedia, Inc. (NASDAQ: NCMI) gained 25.5% to $5.30 after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. The company said it sees first-quarter total revenue of $34.5 million to $35.5 million. Alignment Healthcare, Inc. (NASDAQ: ALHC) gained 17.7% to $5.50. Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose 15% to $43.63 ...

    Benzinga
  • Are penny stocks worth investing in? The post Are Penny Stocks Worth the Risk? 3 Reasons Why They Could Be appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
Page data last updated 07/23/2025 20:45:23 UTC